Chloroquine in COVID-19: the evidence.

Gupta, Nitesh; Agrawal, Sumita; Ish, Pranav

Gupta, Nitesh; Agrawal, Sumita; Ish, Pranav.

Gupta N; Department of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital; Nodal officer for COVID-19, Safdarjung Hospital, New Delhi. niteshgupta2107@gmail.com.
Agrawal S; Department of Pulmonary Medicine, Medipulse Hospital, Jodhpur. drsumi84@gmail.com.
Ish P; Department of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi. pranavish2512@gmail.com.

Monaldi Arch Chest Dis ; 90(1)2020 Mar 31.

Article in English | MEDLINE | ID: covidwho-23855

ABSTRACT

ABSTRACT

To the Editor The Coronavirus disease 2019 (COVID-19) has been declared as a pandemic by World Health Organisation (WHO). The global mortality has increased, especially in countries like Italy and Iran. With the increasing morbidity and mortality, search for a cure has been the global demand.

Subject(s)

Antiviral Agents; Chloroquine/therapeutic use; Coronavirus Infections/drug therapy; Pneumonia, Viral/drug therapy; Antiviral Agents/therapeutic use; Betacoronavirus/drug effects; COVID-19; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Pandemics; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Chloroquine / Coronavirus Infections Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google